<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30459406</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2222-1751</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>21</Day></PubDate></JournalIssue><Title>Emerging microbes &amp; infections</Title><ISOAbbreviation>Emerg Microbes Infect</ISOAbbreviation></Journal><ArticleTitle>Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis.</ArticleTitle><Pagination><StartPage>187</StartPage><MedlinePgn>187</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">187</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41426-018-0191-1</ELocationID><Abstract><AbstractText>The genus Flavivirus contains many important pathogens, including dengue virus (DENV), Zika virus (ZIKV), and Japanese encephalitis virus (JEV). AR-12 is a celecoxib-derived anticancer agent that possesses antiviral activity against a broad range of viruses. We pharmacologically exploited this unique activity to develop additional antiviral agents, resulting in the production of the AR-12 derivatives P12-23 and P12-34. At nanomolar concentrations, these compounds were effective in suppressing DENV, ZIKV and JEV replication, exhibiting 10-fold improvements in the efficacy and selectivity indices as compared to AR-12. Regarding the mode of antiviral action, P12-23 and P12-34 inhibited viral RNA replication but had no effect on viral binding, entry or translation. Moreover, these AR-12 derivatives co-localized with mitochondrial markers, and their antiviral activity was lost in mitochondria-depleted cells. Interestingly, exogenous uridine or orotate, the latter being a metabolite of the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH), abolished the antiviral activity of AR-12 and its derivatives. As DHODH is a key enzyme in the de novo pyrimidine biosynthesis pathway, these AR-12 derivatives may act by targeting pyrimidine biosynthesis in host cells to inhibit viral replication. Importantly, treatment with P12-34 significantly improved the survival of mice that were subcutaneously challenged with DENV. Thus, P12-34 may warrant further evaluation as a therapeutic to control flaviviral outbreaks.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chao-Fu</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biological Chemistry, Academia Sinica, Taipei, 11529, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gopula</LastName><ForeName>Balraj</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute of Biological Chemistry, Academia Sinica, Taipei, 11529, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Drug Development Center, China Medical University, Taichung, 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Jian-Jong</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin-Kun</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Si-Yu</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yi-Ling</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ching S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Institute of Biological Chemistry, Academia Sinica, Taipei, 11529, Taiwan. cschencmu@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Drug Development Center, China Medical University, Taichung, 40402, Taiwan. cschencmu@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, 40447, Taiwan. cschencmu@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yi-Ling</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan. yll@ibms.sinica.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genomic Research Center, Academia Sinica, Taipei, 11529, Taiwan. yll@ibms.sinica.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>106-2101-01-11-01</GrantID><Agency>Academia Sinica</Agency><Country/></Grant><Grant><GrantID>107-2101-01-18-03</GrantID><Agency>Academia Sinica</Agency><Country/></Grant><Grant><GrantID>106-2101-01-11-01</GrantID><Agency>Academia Sinica</Agency><Country/></Grant><Grant><GrantID>MOST 107-0210-01-19-01</GrantID><Agency>Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)</Agency><Country/></Grant><Grant><GrantID>MOST 107-2321-B-001-027</GrantID><Agency>Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Microbes Infect</MedlineTA><NlmUniqueID>101594885</NlmUniqueID><ISSNLinking>2222-1751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000090722">Dihydroorotate Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C500894">OSU 03012</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011720">Pyrazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013449">Sulfonamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.3.-</RegistryNumber><NameOfSubstance UI="D044925">Oxidoreductases Acting on CH-CH Group Donors</NameOfSubstance></Chemical><Chemical><RegistryNumber>K8CXK5Q32L</RegistryNumber><NameOfSubstance UI="C030986">pyrimidine</NameOfSubstance></Chemical><Chemical><RegistryNumber>WHI7HQ7H85</RegistryNumber><NameOfSubstance UI="D014529">Uridine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000072283" MajorTopicYN="N">A549 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053898" MajorTopicYN="N">Biosynthetic Pathways</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090722" MajorTopicYN="N">Dihydroorotate Dehydrogenase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005416" MajorTopicYN="N">Flavivirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044925" MajorTopicYN="N">Oxidoreductases Acting on CH-CH Group Donors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011720" MajorTopicYN="N">Pyrazoles</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013449" MajorTopicYN="N">Sulfonamides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014529" MajorTopicYN="N">Uridine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071244" MajorTopicYN="N">Zika Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30459406</ArticleId><ArticleId IdType="pmc">PMC6246607</ArticleId><ArticleId IdType="doi">10.1038/s41426-018-0191-1</ArticleId><ArticleId IdType="pii">10.1038/s41426-018-0191-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhatt S, et al. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahala WM, Silva AM. The human antibody response to dengue virus infection. Viruses. 2011;3:2374&#x2013;2395. doi: 10.3390/v3122374.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v3122374</ArticleId><ArticleId IdType="pmc">PMC3280510</ArticleId><ArticleId IdType="pubmed">22355444</ArticleId></ArticleIdList></Reference><Reference><Citation>Devakumar Delan, Bamford Alasdair, Ferreira Marcelo U, Broad Jonathan, Rosch Richard E, Groce Nora, Breuer Judith, Cardoso Marly A, Copp Andrew J, Alexandre Paula, Rodrigues Laura C, Abubakar Ibrahim. Infectious causes of microcephaly: epidemiology, pathogenesis, diagnosis, and management. The Lancet Infectious Diseases. 2018;18(1):e1&#x2013;e13. doi: 10.1016/S1473-3099(17)30398-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(17)30398-5</ArticleId><ArticleId IdType="pubmed">28844634</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira WK, et al. Zika virus infection and associated neurologic disorders in Brazil. N. Engl. J. Med. 2017;376:1591&#x2013;1593. doi: 10.1056/NEJMc1608612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1608612</ArticleId><ArticleId IdType="pmc">PMC5544116</ArticleId><ArticleId IdType="pubmed">28402236</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai JH, Lin YL, Hsieh SL. Pharmacological intervention for dengue virus infection. Biochem Pharmacol. 2017;129:14&#x2013;25. doi: 10.1016/j.bcp.2017.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2017.01.005</ArticleId><ArticleId IdType="pubmed">28104437</ArticleId></ArticleIdList></Reference><Reference><Citation>Boldescu V, Behnam MAM, Vasilakis N, Klein CD. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond. Nat. Rev. Drug Discov. 2017;16:565&#x2013;586. doi: 10.1038/nrd.2017.33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2017.33</ArticleId><ArticleId IdType="pmc">PMC5925760</ArticleId><ArticleId IdType="pubmed">28473729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, et al. From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors. Cancer Res. 2004;64:4309&#x2013;4318. doi: 10.1158/0008-5472.CAN-03-4063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-03-4063</ArticleId><ArticleId IdType="pubmed">15205346</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AJ, et al. A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanism. Blood. 2005;105:2504&#x2013;2509. doi: 10.1182/blood-2004-05-1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-05-1957</ArticleId><ArticleId IdType="pubmed">15454489</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu HC, et al. Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent. Antimicrob. Agents Chemother. 2009;53:5236&#x2013;5244. doi: 10.1128/AAC.00555-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00555-09</ArticleId><ArticleId IdType="pmc">PMC2786354</ArticleId><ArticleId IdType="pubmed">19805568</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu HC, et al. Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent. J. Biomed. Sci. 2009;16:110. doi: 10.1186/1423-0127-16-110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-16-110</ArticleId><ArticleId IdType="pmc">PMC2801672</ArticleId><ArticleId IdType="pubmed">20003180</ArticleId></ArticleIdList></Reference><Reference><Citation>Koselny K, et al. Antitumor/antifungal celecoxib derivative AR-12 is a non-nucleoside inhibitor of the ANL-family adenylating enzyme acetyl CoA synthetase. ACS Infect. Dis. 2016;2:268&#x2013;280. doi: 10.1021/acsinfecdis.5b00134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.5b00134</ArticleId><ArticleId IdType="pmc">PMC4828684</ArticleId><ArticleId IdType="pubmed">27088128</ArticleId></ArticleIdList></Reference><Reference><Citation>Collier MA, et al. Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles. Int J. Pharm. 2016;499:186&#x2013;194. doi: 10.1016/j.ijpharm.2016.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpharm.2016.01.004</ArticleId><ArticleId IdType="pmc">PMC5730989</ArticleId><ArticleId IdType="pubmed">26768723</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth L, et al. AR-12 inhibits multiple chaperones concomitant with stimulating autophagosome formation collectively preventing virus replication. J. Cell Physiol. 2016;231:2286&#x2013;2302. doi: 10.1002/jcp.25431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25431</ArticleId><ArticleId IdType="pmc">PMC6327852</ArticleId><ArticleId IdType="pubmed">27187154</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HH, et al. AR-12 suppresses dengue virus replication by down-regulation of PI3K/AKT and GRP78. Antivir. Res. 2017;142:158&#x2013;168. doi: 10.1016/j.antiviral.2017.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.02.015</ArticleId><ArticleId IdType="pubmed">28238876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr EL, et al. Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses. Antivir. Res. 2015;120:40&#x2013;47. doi: 10.1016/j.antiviral.2015.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.05.003</ArticleId><ArticleId IdType="pubmed">25986249</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 1997;3:866&#x2013;871. doi: 10.1038/nm0897-866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0897-866</ArticleId><ArticleId IdType="pubmed">9256277</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Schaar HM, et al. Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog. 2008;4:e1000244. doi: 10.1371/journal.ppat.1000244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000244</ArticleId><ArticleId IdType="pmc">PMC2592694</ArticleId><ArticleId IdType="pubmed">19096510</ArticleId></ArticleIdList></Reference><Reference><Citation>von Kleist L, et al. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell. 2011;146:471&#x2013;484. doi: 10.1016/j.cell.2011.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.06.025</ArticleId><ArticleId IdType="pubmed">21816279</ArticleId></ArticleIdList></Reference><Reference><Citation>Taguwa S, et al. Defining Hsp70 subnetworks in dengue virus replication reveals key vulnerability in flavivirus infection. Cell. 2015;163:1108&#x2013;1123. doi: 10.1016/j.cell.2015.10.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.10.046</ArticleId><ArticleId IdType="pmc">PMC4869517</ArticleId><ArticleId IdType="pubmed">26582131</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldring ES, Grossman LI, Krupnick D, Cryer DR, Marmur J. The petite mutation in yeast. Loss of mitochondrial deoxyribonucleic acid during induction of petites with ethidium bromide. J. Mol. Biol. 1970;52:323&#x2013;335. doi: 10.1016/0022-2836(70)90033-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2836(70)90033-1</ArticleId><ArticleId IdType="pubmed">5485912</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis RAG, Calil FA, Feliciano PR, Pinheiro MP, Nonato MC. The dihydroorotate dehydrogenases: past and present. Arch. Biochem Biophys. 2017;632:175&#x2013;191. doi: 10.1016/j.abb.2017.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2017.06.019</ArticleId><ArticleId IdType="pubmed">28666740</ArticleId></ArticleIdList></Reference><Reference><Citation>Deans RM, et al. Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification. Nat. Chem. Biol. 2016;12:361&#x2013;366. doi: 10.1038/nchembio.2050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.2050</ArticleId><ArticleId IdType="pmc">PMC4836973</ArticleId><ArticleId IdType="pubmed">27018887</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters GJ, Sharma SL, Laurensse E, Pinedo HM. Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390) Invest New Drugs. 1987;5:235&#x2013;244. doi: 10.1007/BF00175293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00175293</ArticleId><ArticleId IdType="pubmed">2822596</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveh A, et al. Discovery of potent broad spectrum antivirals derived from marine actinobacteria. PLoS One. 2013;8:e82318. doi: 10.1371/journal.pone.0082318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082318</ArticleId><ArticleId IdType="pmc">PMC3857800</ArticleId><ArticleId IdType="pubmed">24349254</ArticleId></ArticleIdList></Reference><Reference><Citation>Khutornenko AA, Dalina AA, Chernyak BV, Chumakov PM, Evstafieva AG. The role of dihydroorotate dehydrogenase in apoptosis induction in response to inhibition of the mitochondrial respiratory chain complex III. Acta Nat. 2014;6:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3999468</ArticleId><ArticleId IdType="pubmed">24772329</ArticleId></ArticleIdList></Reference><Reference><Citation>Luthra P, et al. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses. Antivir. Res. 2018;158:288&#x2013;302. doi: 10.1016/j.antiviral.2018.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.08.012</ArticleId><ArticleId IdType="pmc">PMC6436837</ArticleId><ArticleId IdType="pubmed">30144461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas-Hourani M, et al. Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity. PLoS Pathog. 2013;9:e1003678. doi: 10.1371/journal.ppat.1003678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003678</ArticleId><ArticleId IdType="pmc">PMC3789760</ArticleId><ArticleId IdType="pubmed">24098125</ArticleId></ArticleIdList></Reference><Reference><Citation>Zellweger RM, Shresta S. Mouse models to study dengue virus immunology and pathogenesis. Front Immunol. 2014;5:151. doi: 10.3389/fimmu.2014.00151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00151</ArticleId><ArticleId IdType="pmc">PMC3989707</ArticleId><ArticleId IdType="pubmed">24782859</ArticleId></ArticleIdList></Reference><Reference><Citation>Simanjuntak Y, Liang JJ, Lee YL, Lin YL. Repurposing of prochlorperazine for use against dengue virus infection. J. Infect. Dis. 2015;211:394&#x2013;404. doi: 10.1093/infdis/jiu377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu377</ArticleId><ArticleId IdType="pubmed">25028694</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang QY, et al. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis. J. Virol. 2011;85:6548&#x2013;6556. doi: 10.1128/JVI.02510-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02510-10</ArticleId><ArticleId IdType="pmc">PMC3126545</ArticleId><ArticleId IdType="pubmed">21507975</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasser T, Moyer JD, Handschumacher RE. Novel single-pass exchange of circulating uridine in rat liver. Science. 1981;213:777&#x2013;778. doi: 10.1126/science.7256279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.7256279</ArticleId><ArticleId IdType="pubmed">7256279</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann HH, Kunz A, Simon VA, Palese P, Shaw ML. Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc. Natl. Acad. Sci. USA. 2011;108:5777&#x2013;5782. doi: 10.1073/pnas.1101143108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1101143108</ArticleId><ArticleId IdType="pmc">PMC3078400</ArticleId><ArticleId IdType="pubmed">21436031</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyssen P, Balzarini J, De Clercq E, Neyts J. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J. Virol. 2005;79:1943&#x2013;1947. doi: 10.1128/JVI.79.3.1943-1947.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.3.1943-1947.2005</ArticleId><ArticleId IdType="pmc">PMC544097</ArticleId><ArticleId IdType="pubmed">15650220</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminizadeh E, Alavian SM, Akbari Sari A, Ebrahimi Daryani N, Behnava B. Safety and efficacy of adding ribavirin to interferon or peginterferon in treatment of hepatitis C infection in patients with thalassemia: a systematic review on randomized controlled trials. Hepat. Mon. 2016;16:e28537. doi: 10.5812/hepatmon.28537.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/hepatmon.28537</ArticleId><ArticleId IdType="pmc">PMC4876663</ArticleId><ArticleId IdType="pubmed">27226796</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans DR, Guy HI. Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway. J. Biol. Chem. 2004;279:33035&#x2013;33038. doi: 10.1074/jbc.R400007200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R400007200</ArticleId><ArticleId IdType="pubmed">15096496</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, et al. Inhibition of canonical WNT/beta-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells. Oncotarget. 2016;7:50401&#x2013;50416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5226591</ArticleId><ArticleId IdType="pubmed">27391060</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawamukai N, et al. Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells. J. Immunol. 2007;179:6479&#x2013;6484. doi: 10.4049/jimmunol.179.10.6479.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.10.6479</ArticleId><ArticleId IdType="pubmed">17982036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z, et al. Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017;392:11&#x2013;21. doi: 10.1016/j.tox.2017.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2017.10.002</ArticleId><ArticleId IdType="pmc">PMC5736314</ArticleId><ArticleId IdType="pubmed">28988120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamed HA, et al. OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteins. Cancer Biol. Ther. 2010;9:526&#x2013;536. doi: 10.4161/cbt.9.7.11116.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cbt.9.7.11116</ArticleId><ArticleId IdType="pmc">PMC2888700</ArticleId><ArticleId IdType="pubmed">20107314</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MA, et al. OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cells. Mol. Pharmacol. 2008;73:1168&#x2013;1184. doi: 10.1124/mol.107.042697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.107.042697</ArticleId><ArticleId IdType="pmc">PMC2674576</ArticleId><ArticleId IdType="pubmed">18182481</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng PH, et al. Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance. Blood. 2005;105:4021&#x2013;4027. doi: 10.1182/blood-2004-07-2967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-07-2967</ArticleId><ArticleId IdType="pmc">PMC1895085</ArticleId><ArticleId IdType="pubmed">15665113</ArticleId></ArticleIdList></Reference><Reference><Citation>Smee DF, Hurst BL, Day CW. D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis. Antivir. Chem. Chemother. 2012;22:263&#x2013;272. doi: 10.3851/IMP2105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3851/IMP2105</ArticleId><ArticleId IdType="pubmed">22516927</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing M, et al. Characterization of dengue virus resistance to brequinar in cell culture. Antimicrob. Agents Chemother. 2010;54:3686&#x2013;3695. doi: 10.1128/AAC.00561-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00561-10</ArticleId><ArticleId IdType="pmc">PMC2934995</ArticleId><ArticleId IdType="pubmed">20606073</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonavia A, et al. Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV) Proc. Natl. Acad. Sci. USA. 2011;108:6739&#x2013;6744. doi: 10.1073/pnas.1017142108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017142108</ArticleId><ArticleId IdType="pmc">PMC3084118</ArticleId><ArticleId IdType="pubmed">21502533</ArticleId></ArticleIdList></Reference><Reference><Citation>Karle JM, Anderson LW, Cysyk RL. Effect of plasma concentrations of uridine on pyrimidine biosynthesis in cultured L1210 cells. J. Biol. Chem. 1984;259:67&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">6323418</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang JJ, Liao CL, Liao JT, Lee YL, Lin YL. A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability. Vaccine. 2009;27:2746&#x2013;2754. doi: 10.1016/j.vaccine.2009.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.03.007</ArticleId><ArticleId IdType="pubmed">19366580</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YL, et al. Study of Dengue virus infection in SCID mice engrafted with human K562 cells. J. Virol. 1998;72:9729&#x2013;9737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110483</ArticleId><ArticleId IdType="pubmed">9811707</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CY, et al. Dengue Virus Impairs Mitochondrial Fusion by Cleaving Mitofusins. PLoS Pathog. 2015;11:e1005350. doi: 10.1371/journal.ppat.1005350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005350</ArticleId><ArticleId IdType="pmc">PMC4696832</ArticleId><ArticleId IdType="pubmed">26717518</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WK, et al. Detection of dengue virus replication in peripheral blood mononuclear cells from dengue virus type 2-infected patients by a reverse transcription-real-time PCR assay. J. Clin. Microbiol. 2002;40:4472&#x2013;4478. doi: 10.1128/JCM.40.12.4472-4478.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.12.4472-4478.2002</ArticleId><ArticleId IdType="pmc">PMC154639</ArticleId><ArticleId IdType="pubmed">12454138</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>